1. Li, Yi, Dörmann, Niklas, Brinschwitz, Björn, Müller, Oliver J, Fielitz, Jens. 2023. SPSB1-mediated inhibition of TGF-β receptor-II impairs myogenesis in inflammation. In Journal of cachexia, sarcopenia and muscle, 14, 1721-1736. doi:10.1002/jcsm.13252. https://pubmed.ncbi.nlm.nih.gov/37209006/
2. Kim, Hyun-Jung, Kim, Hye Jin, Kim, Mi-Kyung, Kim, Seung Cheol, Ju, Woong. 2019. SPSB1 enhances ovarian cancer cell survival by destabilizing p21. In Biochemical and biophysical research communications, 510, 364-369. doi:10.1016/j.bbrc.2019.01.088. https://pubmed.ncbi.nlm.nih.gov/30712944/
3. Feng, Yi, Pan, Tien-Chi, Pant, Dhruv K, Ruth, Jason R, Chodosh, Lewis A. 2014. SPSB1 promotes breast cancer recurrence by potentiating c-MET signaling. In Cancer discovery, 4, 790-803. doi:10.1158/2159-8290.CD-13-0548. https://pubmed.ncbi.nlm.nih.gov/24786206/
4. Seo, Danbi, Roh, Jungwook, Chae, Yeonsoo, Kim, Wanyeon. . Gene expression profiling after LINC00472 overexpression in an NSCLC cell line1. In Cancer biomarkers : section A of Disease markers, 32, 175-188. doi:10.3233/CBM-210242. https://pubmed.ncbi.nlm.nih.gov/34397405/
5. Georgana, Iliana, Maluquer de Motes, Carlos. 2020. Cullin-5 Adaptor SPSB1 Controls NF-κB Activation Downstream of Multiple Signaling Pathways. In Frontiers in immunology, 10, 3121. doi:10.3389/fimmu.2019.03121. https://pubmed.ncbi.nlm.nih.gov/32038638/